JAS UK granted WDA(H) license for its pharma and healthcare division

Securing the license empowers JAS UK's pharma and healthcare division to seamlessly connect with the company’s more than 40 GDP certified overseas stations.  

Global logistics company, JAS has received the Wholesale Distribution Authorisation (WDA(H)) license from the UK’s Medicine and Healthcare Products Regulatory Agency (MHRA) for its Pharma and Healthcare Division.

In a press release issued on Thursday (22 February), the company said that securing the license empowers its UK healthcare division to “seamlessly connect” with its more than 40 GDP (Good Distribution Practice) certified overseas stations, strengthening its capabilities for handling pharmaceutical shipments.

Headquartered in Atlanta, Georgia, USA, the company boasts a team of over 7,000 professionals, with operations spanning over 100 countries.

Adrian Frodsham, Regional Director for JAS, said that they were granted the WDA(H) license after a “stringent audit process.”

“JAS UK's pharma and healthcare division prides itself of offering innovative solutions for the international delivery of pharmaceutical products, further enhancing the growth of our pre-established healthcare division,” he added.

JAS UK said that its purpose-built healthcare and pharmaceutical Electronic Quality Management System (QMS), coupled with the WDA(H) license, further solidifies the company’s position as a trusted operator within the logistics industry.

As part of its expansion initiatives, JAS UK's pharma and healthcare division recently inaugurated a state-of-the-art temperature-controlled storage facility in London.

“Spread across 5000 square feet, this facility features two CRT rooms designed to accommodate products requiring temperatures of 15°C to 25°C. Strategically located near London Heathrow Airport, the facility ensures the integrity of pharmaceutical products throughout the supply chain, providing customers with a safe, secure, and efficient door-to-door service,” it said.